CenterWatch
presents its latest report in a series on emerging markets in the clinical
trials industry—Central and Eastern Europe:
Outsourcing Trends and Growth Opportunities in Clinical Trials. The number of clinical trials
initiated in Central and Eastern Europe more
than tripled from 2002 to 2007, making the region a key part of global clinical
research. This comprehensive
analysis focuses on the evolution of the clinical trials industry in the CEE
region and the outsourcing strategies that CROs and emerging pharmaceutical and
biotech companies need to operate there.
Topics
include:
- Market information on
25+ countries including: Bulgaria,
Czech Republic,
Hungary, Poland, Romania,
Russia, Turkey and Ukraine
- EU directives and other
European regulatory trends
- Exclusive interviews with executives from
the top CROs
- Factors driving growth
- Companies acquiring
local CROs and why
- Current drug
development pipeline
- Original and proprietary CenterWatch
charts and graphs
Central and
Eastern Europe
is recommended for:
- Biotech and
pharmaceutical companies seeking information on growth and challenges in
the Central and Eastern Europe market
- Investment firms
covering the life sciences industry in emerging markets
- CROs conducting
business in Central and Eastern European countries
Don’t
miss out on this important resource detailing the growing clinical trials
industry in Central and Eastern Europe!
To preview
the Table of Contents and other sample pages, click on the links below:
Table of Contents
Introduction
Central and
Eastern Europe: Outsourcing Trends and Growth Opportunities in Clinical Trials is available as a printable PDF or as a printed report. Multiple copies and site licenses are
also available. For more information, please call (866) 219-3440, ext 1, or
email sales@centerwatch.com.
For
a faxable order form, click here.
Price: $995.
